Seeing Is Believing
Healthcare - Sector
CRL is currently covered by 10 analysts with an average price target of $227.9. This is a potential upside of $31.02 (-19.09%) from yesterday's end of day stock price of $281.67.
Charles River Laboratories's activity chart (see below) currently has 218 price targets and 163 ratings on display. The stock rating distribution of CRL is 48.28% HOLD and 51.72% BUY.
Analysts average stock forecasts to be materialized ratio is 80.9% with an average time for these price targets to be met of 143.24 days.
Highest price target for CRL is $320, Lowest price target is $160, average price target is $227.9.
Most recent stock forecast was given by ROSS MUKEN from EVERCORE on 10-Sep-2026. First documented stock forecast 13-Mar-2014.
Currently out of the existing stock ratings of CRL, 14 are a HOLD (48.28%), 15 are a BUY (51.72%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 29-Apr-2019
$320
$41.74 (15.00%)
$300
7 days ago
(10-Sep-2026)
5/7 (71.43%)
$41.74 (15.00%)
140
Buy Since 12-Oct-2025
$300
$21.74 (7.81%)
$235
1 months 8 days ago
(09-Aug-2026)
12/13 (92.31%)
$23 (8.30%)
188
Hold Since 02-Feb-2025
$310
$31.74 (11.41%)
$160
1 months 12 days ago
(05-Aug-2026)
6/7 (85.71%)
$44.49 (16.76%)
25
Hold Since 06-Jun-2024
$230
$-48.26 (-17.34%)
$175
2 months 5 days ago
(12-Jul-2026)
9/9 (100%)
$0.25 (0.11%)
36
Hold Since 04-Aug-2022
$220
$4.25 (1.97%)
$168
3 months ago
(17-Jun-2026)
10/11 (90.91%)
$37.66 (20.65%)
159
What is CRL (Charles River Laboratories) average time for price targets to be met?
Which analyst most recently updated their price target on CRL (Charles River Laboratories)?
Which analyst has the most public recommendations on CRL (Charles River Laboratories)?
Which analyst is the currently most bullish on CRL (Charles River Laboratories)?
Which analyst is the currently most reserved on CRL (Charles River Laboratories)?